SC
USNA icon

Sculptor Capital’s Usana Health Sciences USNA Stock Holding History

Sculptor Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,000
Closed -$2.88M – 180
2017
Q3 		$2.88M Hold
50,000
– – 0.01% 194
2017
Q2 		$3.21M Buy
+50,000
New +$3.08M 0.02% 201

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Sculptor Capital's USNA Position: Q4 2013 in Review

Sculptor Capital sold out of Usana Health Sciences (USNA) in Q4 2013, closing a stake of 3,800 shares — an estimated $165K sold.

Sculptor Capital first reported a position in USNA in Q2 2013 and held it in 2 quarters. The position peaked at $1.71M in Q2 2013. 130 funds tracked by Wall St. Rank hold USNA as of Q4 2013.

  • Sculptor Capital reported no remaining Usana Health Sciences position as of Q4 2013 after selling out during the quarter.
  • Sculptor Capital sold 3,800 Usana Health Sciences shares in Q4 2013, an estimated $165K.
  • Sculptor Capital first reported a position in Usana Health Sciences in Q2 2013 and held it in 2 quarters.
  • Sculptor Capital's Usana Health Sciences position peaked at $1.71M in Q2 2013.
  • 130 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2013.

Based on Sculptor Capital's 13F filing for Q4 2013, filed 14 Feb 2014.